Xiaojie Xu

6PUBLICATIONS
19CO-AUTHORS
Cancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 18, 2026
Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in pancreatic ductal adenocarcinoma.

|Apr 25, 2026
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.

|Mar 21, 2026
Dalpiciclib plus chidamide in HR + /HER2-advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial.

Jinmei Zhou, Xuexue Wu, Yimeng Du

|Dec 01, 2023
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.

Zhijia Sun, Haixing Mai, Chunyuan Xue

|Apr 12, 2022
SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma.

Zhongyi Fan, Jingjing Duan, Pu Luo

|Aug 18, 2021
STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.

Nan Huo, Rui Cong, Zhi-Jia Sun

Pageof 1

Frequent Collaborators

2 joint publications

Tao Wang

1 joint publications

Nan Huo

1 joint publications

Zhi-Jia Sun

1 joint publications

Nan Du